Cempra (CEMP) January volatility above 200 into FDA PDUFA Date

Cempra (NASDAQ: CEMP) January call option implied volatility is at 201, February is at 154; compared to its 52-week range of 69 to 260 into a FDA PDUFA Date for Cempra Oral Solithromycin IV formulation on December 28, 2016.

You May Also Be Interested In

• iShares 20+ Year Treasury Bond ETF (TLT) spreader of 57120 contracts of December 80 and 84 calls
• Birkenstock Holding (BIRK) 2K contracts of November 35 calls trade
• iShares MSCI Brazil (EWZ) spreader of 12267 contracts of October 9 weekly 38, 40.50 and 41.50 calls amid Presidential elections, energy and commodity prices